Elitek (Rasburicase) Immuno-Monitoring Study

Clinical trial NCT01097369 · TERMINATED

Trial details

NCT number: NCT01097369
Sponsor: Sanofi
Status: TERMINATED
Study type: OBSERVATIONAL

Tumor Lysis Syndrome

Start date: 2010-02-01
Primary completion: 2010-02-01
Enrollment: 1

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.